Hepatic mitochondrial metabolic pathways

Hepatic mitochondrial metabolic pathways represent the integrated network of biochemical processes within liver mitochondria that maintain systemic energy balance. These pathways include the tricarboxylic acid (TCA) cycle, oxidative phosphorylation, fatty acid beta-oxidation, and the urea cycle, which collectively manage the conversion of nutrients into cellular energy (ATP) and metabolic intermediates (Source: NIH/NCBI). In the liver, these pathways are essential for gluconeogenesis and ketogenesis, ensuring a steady supply of fuel to the brain and muscles during fasting (Source: Journal of Hepatology). Dysfunction in these pathways, often characterized by impaired oxidative capacity or excessive reactive oxygen species production, is a primary driver of metabolic diseases such as metabolic dysfunction-associated steatotic liver disease (MASLD) and insulin resistance (Source: Nature Reviews Gastroenterology & Hepatology). Therapeutic strategies often target specific components within these pathways, such as the mitochondrial pyruvate carrier or respiratory complex I, to improve metabolic efficiency and reduce lipid accumulation (Source: Cell Metabolism). However, targeting these fundamental processes requires careful management to avoid systemic toxicity, such as lactic acidosis or impaired ATP production in non-target tissues (Source: StatPearls).

Other names

Liver mitochondrial metabolismHepatic mitochondrial functionHepatic mitochondrial bioenergetics

Modulation of mitochondrial respiratory chain activity, inhibition of mitochondrial pyruvate transport, and activation of fatty acid oxidation via nuclear receptor signaling.